0 NASDAQ Companies - March 14, 2025Blue Hat Teams Up with Axis Capital Group to Pioneer Innovation in Gold RWAHONG KONG, March 14, 2025 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT) […]Read More
0 NASDAQ Companies - March 14, 2025Gogo Announces Fourth Quarter and Full Year 2024 ResultsTotal Revenue of $137.8 million, up 41% Year-over-Year; Fourth Quarter Service Revenue of $118.8 million, up 47% Year-over-Year Q4 Net […]Read More
0 NASDAQ Companies - March 14, 2025Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for First Quarter 2025NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that […]Read More
0 NASDAQ Companies - March 14, 2025Iridex Comments on Recent Stock Price VolatilityMOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based […]Read More
0 NASDAQ Companies - March 14, 2025Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on […]Read More
0 NASDAQ Companies - March 14, 2025FangDD Announces US$5,000,000 Senior Convertible Notes OfferingSHENZHEN, China, March 14, 2025 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”), a customer-oriented […]Read More
0 NASDAQ Companies - March 14, 2025CareCloud Announces Preferred Stock Dividend PaymentsSOMERSET, N.J., March 14, 2025 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare […]Read More
0 NASDAQ Companies - March 14, 2025Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600– Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study –– Company expects to submit New Drug Application (NDA) […]Read More
0 NASDAQ Companies - March 14, 2025ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® LabelILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition […]Read More
0 NASDAQ Companies - March 14, 2025Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyHONG KONG, March 14, 2025 (GLOBE NEWSWIRE) — Primega Group Holdings Limited (Nasdaq: PGHL) (the “Company”) announced that, on March […]Read More